Susquehanna Fundamental Investments, LLC Wave Life Sciences Ltd. Transaction History
Susquehanna Fundamental Investments, LLC
- $4.33 Trillion
- Q2 2024
A detailed history of Susquehanna Fundamental Investments, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 18,744 shares of WVE stock, worth $267,476. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,744
Previous 65,565
71.41%
Holding current value
$267,476
Previous $405 Million
76.88%
% of portfolio
0.0%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding WVE
# of Institutions
164Shares Held
117MCall Options Held
148KPut Options Held
109K-
Ra Capital Management, L.P. Boston, MA18.2MShares$260 Million2.08% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10MShares$143 Million1.71% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$138 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$96.2 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$88 Million48.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.24B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...